As part of the expansion of Satisnet Limited, who will provide third party assurance technology to its clients.partner programme, it has announced a collaboration with leading security reseller and managed security services provider
Satisnet will help its customers take control of third party risks through Crossword's Rizikon Assurance third party risk management platform. The platform will allow Rizikon customers to proactively managed their risk by automating supplier onboarding and gaining full visibility of third-party risk exposure. Customers will also be able to fully outsource their assurance processes to Satisnet through the Third-Party Assurance as a Service offering. Through Rizikon Assurance, Satisnet will help customers manage this risk at scale whilst improving the experience for their suppliers.
Shares in Crossword opened slightly lower at 340p in early trade
Sean Arrowsmith, Group Sales Director at Crossword Cybersecurity PLC, said: "We are really excited to have signed this agreement with Satisnet and it is a great step forward, as we progress our partner programme. Rizikon Assurance compliments Satisnet's existing portfolio and will allow their clients to really take control of their supply chain assurance programmes."
John McCann, CEO, Satisnet, said: "The Rizikon Assurance platform is a welcome addition to our offering. A lot of our clients are keen to further mature and enhance their approach to third party risk management and Rizikon will allow them to do this by driving automation at scale into the process."
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
AstraZeneca said it will be able to supply two billion doses of a potential virus vaccine following two new deals. Last month, AstraZeneca said it could manufacture one billion doses, that it is developing with scientists at Oxford University but yesterday after signing two deals, including one backed by Bill Gates, means it can double production.
Cluff said it is ‘fully committed’ to drilling a Shell-partnered North Sea prospect, but that drilling at the Selene prospect is now expected to start in 2022. Meanwhile, the Company remains fully funded for all its other planned drilling operations.